Compound class:
Synthetic organic
Comment: SSYA10-001 is a noncompetitive inhibitor of nsp13 from human betacoronaviruses [2]. It inhibits the helicase activity of nsp13 [1]. Nsp13 is viral helicase that unwinds DNA and RNA in the 5′−3′ direction that is critical forviral replication. It has been identified as a promising target for antiviral drug development. Broad-spectrum activity of SSYA10-001 has been demonstrated, including antiviral activity against SARS-CoV, MERS-CoV and SARS-CoV-2 (including Omicron variants) [3].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
SSYA10-001 inhibits the helicase dsRNA unwinding activity of nsp13 (SARS-CoV) with an in vitro IC50 of 5.7 μM, and inhibits SARS-CoV replication with an EC50 of ~9 μM [1]. |
Selectivity at other protein targets | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|